CO5500021A1 - Anticuerpo monoclonalproducido por la linea de celulas con numero de deposito atcc-pta4837 - Google Patents
Anticuerpo monoclonalproducido por la linea de celulas con numero de deposito atcc-pta4837Info
- Publication number
- CO5500021A1 CO5500021A1 CO03078836A CO03078836A CO5500021A1 CO 5500021 A1 CO5500021 A1 CO 5500021A1 CO 03078836 A CO03078836 A CO 03078836A CO 03078836 A CO03078836 A CO 03078836A CO 5500021 A1 CO5500021 A1 CO 5500021A1
- Authority
- CO
- Colombia
- Prior art keywords
- monoclonal antibody
- ivf
- antibody according
- cell line
- glycoprotein
- Prior art date
Links
- 108090000288 Glycoproteins Proteins 0.000 abstract 3
- 102000003886 Glycoproteins Human genes 0.000 abstract 3
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1036—Retroviridae, e.g. leukemia viruses
- C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
- C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- AIDS & HIV (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Anticuerpo monoclonal específico para un epítopo único para una glicoproteína codificada por FIV inactivado. Anticuerpo monoclonal de acuerdo con la reivindicación 1 en el cual el FIV inactivado es FIV-Shiz o FIV-Petaluma. Anticuerpo monoclonal de acuerdo con la reivindicación 1 ó 2, en el cual dicha glicoproteína es gp95 o gp130. Anticuerpo monoclonal de acuerdo con cualquiera de las reivindicaciones precedentes producido a partir de la línea de células depositada como ATCC número PTA-4837. Anticuerpo monoclonal de acuerdo con cualquiera de las reivindicaciones precedentes que es mAb 1D9. Anticuerpo monoclonal de acuerdo con la reivindicación 3, en el cual dicha glicoproteína es gp95. Anticuerpo monoclonal de acuerdo con la reivindicación 2, en el cual dicho FIV es FIV-Shiz. SOLICITUDES DE PATENTES DE MODELO DE UTILIDADORDENADAS PUBLICAR EN FEBRERO DE 2005 IMPORTANTE:SOLICITUDES DE PATENTE DE MODELO DE UTILIDAD: A partir de la fecha de publicación de esta gaceta el solicitante cuenta con un plazo de tres (3) meses para pedir que se practique el examen de patentabilidad de la solicitud, anexando el recibo de pago de la tasa correspondiente a tal fin. De no procederse así la solicitud caerá en abandono (Arts. 85 y 44 de la Decisión 486).
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41024602P | 2002-09-12 | 2002-09-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO5500021A1 true CO5500021A1 (es) | 2005-03-31 |
Family
ID=31888412
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO03078836A CO5500021A1 (es) | 2002-09-12 | 2003-09-09 | Anticuerpo monoclonalproducido por la linea de celulas con numero de deposito atcc-pta4837 |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US7345152B2 (es) |
| EP (2) | EP2281838A1 (es) |
| JP (1) | JP4472298B2 (es) |
| KR (1) | KR101114268B1 (es) |
| CN (1) | CN1528791B (es) |
| AR (1) | AR041230A1 (es) |
| AT (1) | ATE553126T1 (es) |
| AU (2) | AU2003246049A1 (es) |
| BR (1) | BR0303500B1 (es) |
| CO (1) | CO5500021A1 (es) |
| CY (1) | CY1112710T1 (es) |
| DK (1) | DK1398325T3 (es) |
| ES (1) | ES2383075T3 (es) |
| HR (1) | HRP20030729A2 (es) |
| MX (1) | MXPA03008083A (es) |
| NZ (1) | NZ528160A (es) |
| PL (1) | PL362164A1 (es) |
| PT (1) | PT1398325E (es) |
| RS (1) | RS51739B (es) |
| SI (1) | SI1398325T1 (es) |
| TW (1) | TW200406421A (es) |
| ZA (1) | ZA200307119B (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1624785B1 (en) | 2003-01-17 | 2013-07-17 | Aethlon Medical, Inc. | Method for removal of viruses from blood by lectin affinity hemodialysis |
| CN102735853B (zh) * | 2012-06-07 | 2014-06-04 | 广州市华南农大生物药品有限公司 | 一种猪流感灭活疫苗的效价测定方法 |
| RU2018123480A (ru) * | 2015-12-23 | 2020-01-24 | Интервет Интернэшнл Б.В. | Вакцина против кошачьего калицивируса |
| CN110501509A (zh) * | 2019-09-03 | 2019-11-26 | 长春西诺生物科技有限公司 | 一种抗猫细小病毒猫源化基因工程抗体elisa试剂盒及其检测方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6107077A (en) * | 1987-08-26 | 2000-08-22 | Yamamoto; Janet K. | Feline lymphoid cell lines capable of producing FIV for FIV diagnostics and vaccines |
| CA1341439C (en) * | 1987-08-26 | 2003-09-23 | Niels C. Pedersen | Feline t-lymphotropic lentivirus |
| US5219725A (en) * | 1988-12-05 | 1993-06-15 | Idexx Laboratories Incorporated | Monoclonal antibodies to feline-t-lymphotropic lentivirus |
| US5177014A (en) * | 1988-12-05 | 1993-01-05 | Idexx Laboratories, Inc. | Monoclonal antibodies to feline-T-lymphotropic lentivirus |
| US6228608B1 (en) | 1991-02-28 | 2001-05-08 | Aquila Biopharmaceuticals, Inc. | Recombinant FIV glycoprotein 160 and P24 gag protein |
| GB9215233D0 (en) | 1992-07-17 | 1992-09-02 | Pitman Moore Inc | Vaccines |
| WO1994020622A1 (en) | 1993-03-11 | 1994-09-15 | Akzo Nobel N.V. | Polypeptide fragment capable of inducing neutralising antibodies against feline immuno-deficiency virus |
| US6015686A (en) * | 1993-09-15 | 2000-01-18 | Chiron Viagene, Inc. | Eukaryotic layered vector initiation systems |
| US6254872B1 (en) | 1995-08-25 | 2001-07-03 | University Of Florida | Multi-subtype FIV vaccines |
| ATE313629T1 (de) | 1998-08-24 | 2006-01-15 | Pfizer Prod Inc | Immunschwächevirus stamm fiv-141 der katze und dessen verwendungen |
-
2003
- 2003-08-26 US US10/648,667 patent/US7345152B2/en not_active Expired - Lifetime
- 2003-09-08 MX MXPA03008083A patent/MXPA03008083A/es active IP Right Grant
- 2003-09-08 KR KR1020030062762A patent/KR101114268B1/ko not_active IP Right Cessation
- 2003-09-09 CO CO03078836A patent/CO5500021A1/es not_active Application Discontinuation
- 2003-09-10 SI SI200332137T patent/SI1398325T1/sl unknown
- 2003-09-10 ES ES03255660T patent/ES2383075T3/es not_active Expired - Lifetime
- 2003-09-10 DK DK03255660.7T patent/DK1398325T3/da active
- 2003-09-10 EP EP10183768A patent/EP2281838A1/en not_active Withdrawn
- 2003-09-10 AT AT03255660T patent/ATE553126T1/de active
- 2003-09-10 JP JP2003318535A patent/JP4472298B2/ja not_active Expired - Fee Related
- 2003-09-10 BR BRPI0303500-0B1A patent/BR0303500B1/pt not_active IP Right Cessation
- 2003-09-10 EP EP03255660A patent/EP1398325B1/en not_active Expired - Lifetime
- 2003-09-10 PT PT03255660T patent/PT1398325E/pt unknown
- 2003-09-11 CN CN031649092A patent/CN1528791B/zh not_active Expired - Fee Related
- 2003-09-11 NZ NZ528160A patent/NZ528160A/en not_active IP Right Cessation
- 2003-09-11 ZA ZA2003/07119A patent/ZA200307119B/en unknown
- 2003-09-11 AR ARP030103289A patent/AR041230A1/es active IP Right Grant
- 2003-09-11 HR HR20030729A patent/HRP20030729A2/xx not_active Application Discontinuation
- 2003-09-11 AU AU2003246049A patent/AU2003246049A1/en not_active Abandoned
- 2003-09-12 RS YU71803A patent/RS51739B/sr unknown
- 2003-09-12 TW TW092125182A patent/TW200406421A/zh unknown
- 2003-09-12 PL PL03362164A patent/PL362164A1/xx unknown
-
2010
- 2010-09-22 AU AU2010224370A patent/AU2010224370B2/en not_active Expired
-
2012
- 2012-05-03 CY CY20121100411T patent/CY1112710T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CY1112710T1 (el) | 2016-02-10 |
| KR20040024490A (ko) | 2004-03-20 |
| ZA200307119B (en) | 2005-05-25 |
| YU71803A (sh) | 2006-05-25 |
| ATE553126T1 (de) | 2012-04-15 |
| EP2281838A1 (en) | 2011-02-09 |
| CN1528791B (zh) | 2012-09-05 |
| HRP20030729A2 (en) | 2005-02-28 |
| PL362164A1 (en) | 2004-03-22 |
| BR0303500A (pt) | 2004-09-08 |
| RS51739B (sr) | 2011-10-31 |
| PT1398325E (pt) | 2012-05-29 |
| ES2383075T3 (es) | 2012-06-18 |
| MXPA03008083A (es) | 2004-11-29 |
| KR101114268B1 (ko) | 2012-03-05 |
| CN1528791A (zh) | 2004-09-15 |
| BR0303500B1 (pt) | 2013-09-17 |
| SI1398325T1 (sl) | 2012-06-29 |
| JP2004097225A (ja) | 2004-04-02 |
| NZ528160A (en) | 2005-07-29 |
| AU2010224370A1 (en) | 2010-10-14 |
| US7345152B2 (en) | 2008-03-18 |
| AR041230A1 (es) | 2005-05-11 |
| AU2003246049A1 (en) | 2004-04-01 |
| EP1398325B1 (en) | 2012-04-11 |
| US20040053224A1 (en) | 2004-03-18 |
| TW200406421A (en) | 2004-05-01 |
| JP4472298B2 (ja) | 2010-06-02 |
| EP1398325A1 (en) | 2004-03-17 |
| AU2010224370B2 (en) | 2011-07-21 |
| DK1398325T3 (da) | 2012-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2559763T3 (es) | Anticuerpo humano específico de CD3 con propiedades inmunosupresoras | |
| CO5730020A1 (es) | Interfaces de usuario mejoradas para aplicaciones de software para computador | |
| WO2019008123A3 (en) | CELLS, VERTEBRATES, POPULATIONS AND METHODS | |
| RS54762B1 (sr) | Solubilna humana st-2 antitela i eseji | |
| BR112013022209A2 (pt) | preparação farmacêutica sólida revestida | |
| RS53752B1 (en) | ANTITELO PROTIV ILT7 | |
| CO5500021A1 (es) | Anticuerpo monoclonalproducido por la linea de celulas con numero de deposito atcc-pta4837 | |
| ES2625823T3 (es) | Anticuerpo anti-FGF23 y composición farmacéutica que comprende el mismo | |
| PL439807A1 (pl) | Sposoby oczyszczania przeciwciał i ich kompozycje | |
| WO2009017161A1 (ja) | 炎症性サイトカインの抑制剤 | |
| JP2017527268A5 (es) | ||
| Okonofua et al. | Royal College of Obstetricians and Gynecologists (RCOG) champions’ network: A new agenda for women’s health reform in sub-Saharan Africa | |
| Dahlander | Managing beyond firm boundaries: Leveraging user innovation networks. | |
| Srinivasan et al. | Build and Manage a Lean Supply Chain. | |
| El Frissi et al. | Jensen type inequalities for twice differentiable functions | |
| PE20210103A1 (es) | Anticuerpo monoclonal de la glucoproteina g del virus de la laringotraqueitis infecciosa aviar y aplicaciones del mismo | |
| Geerdink | Stadsdichterschap in de zeventiende eeuw: Jan Vos (1610-1667) en Amsterdam | |
| Pritula et al. | PRACTICE OF APPLICATION OF THE PROJECT MANAGEMENT METHODOLOGY AT THE MUNICIPAL LEVEL | |
| Садриддинов et al. | THEORETICAL ASPECTS OF RESOURCE MANAGEMENT PROCESSES FOR THE DEVELOPMENT OF THE NATIONAL ECONOMY | |
| UA3835U (uk) | Спосіб формування синтетичних популяцій тетраплоїдних цукрових буряків на цитогенетичній основі | |
| Талянина | E-mail: colonel_t2002@ mail. ru | |
| Loveless | Faculty Action Sheet | |
| Novykova | THE MONITORING SYSTEM OF BUILDING COMPETITIVENESS OF ENTERPRISES IN THE TECHNOLOGICAL CHANGES | |
| Aksyutin | Science & technology issues associated with natural gas production transmission and processing | |
| CL2023001651A1 (es) | Anticuerpo anti-epha4 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application lapsed |